Red color represents old content. It may be empty showing addition in the new version.
Green color represents new content. It may be empty showing deletion in the new version.
Inline
Side by side
Added new contents,
deleted old contents,contents that are not changed.
New table contents
New table contents
Old table contents
Old table contents
Unchanged contents
Unchanged contents
Added new contents, contents that are not changed.
Deleted old contents, contents that are not changed.
Old table contents
Old table contents
Unchanged contents
Unchanged contents
New table contents
New table contents
Unchanged contents
Unchanged contents
General information
empty
The updating process was done after publishing the paper to correct the registration information.
The updating process was done after publishing the paper to correct the registration information.
empty
پروسه بروزرسانی پس از انتشار مقاله به منظور تصحیح اطلاعات ثبت انجام گرفت.
پروسه بروزرسانی پس از انتشار مقاله به منظور تصحیح اطلاعات ثبت انجام گرفت.
empty
empty
Primary outcomes
#1
In serum sample will assessed by ELISA kit. μIU/ml
ELISA kit
In serum sample will assessed by ELISA kit. μIU/ml
انجام آزمایش بر روی سرم به روش الایزا بر حسب میکرو واحد بین المللی بر میلی لیتر
کیت الایزا
انجام آزمایش بر روی سرم به روشکیت الایزا بر حسب میکرو واحد بین المللی بر میلی لیتر
#2
Free Testosterone
SHBG
Free TestosteroneSHBG
تستوسترون آزاد
SHBG
تستوسترون آزادSHBG
In serum sample will assessed by ELISA kit. μIU/ml
ELISA kit
In serum sample will assessed by ELISA kit. μIU/ml
انجام آزمایش بر روی سرم به روش الایزا بر حسب میکرو واحد بین المللی بر میلی لیتر
کیت الایزا
انجام آزمایش بر روی سرم به روشکیت الایزا بر حسب میکرو واحد بین المللی بر میلی لیتر
#3
DHEA Sulfate
Serum insulin
DHEA SulfateSerum insulin
DHEA سولفاته
انسولین سرم
DHEA سولفاتهانسولین سرم
In serum sample will assessed by ELISA kit. μIU/ml
Elisa kit
In serum sample will assessed by ELISAElisa kit. μIU/ml
انجام آزمایش بر روی سرم به روش الایزا بر حسب میکرو واحد بین المللی بر میلی لیتر
کیت الایزا
انجام آزمایش بر روی سرم به روشکیت الایزا بر حسب میکرو واحد بین المللی بر میلی لیتر
#4
SHBG
Insulin resistance
SHBGInsulin resistance
SHBG
مقاومت به انسولین
SHBGمقاومت به انسولین
In serum sample will assessed by ELISA kit. μIU/ml
Calculated with suggested formula
In serum sample will assessed by ELISA kit. μIU/mlCalculated with suggested formula
انجام آزمایش بر روی سرم به روش الایزا بر حسب میکرو واحد بین المللی بر میلی لیتر
محاسبه شده با فرمولای پیشنهادی
انجام آزمایش بر روی سرم به روش الایزا بر حسب میکرو واحد بین المللی بر میلی لیترمحاسبه شده با فرمولای پیشنهادی
#5
empty
Insulin sensitivity
Insulin sensitivity
empty
حساسیت به انسولین
حساسیت به انسولین
empty
At the beginning of the study and 12 weeks after intervention
At the beginning of the study and 12 weeks after intervention
empty
در ابتدای مطالعه و 12 هفته بعد از مداخله
در ابتدای مطالعه و 12 هفته بعد از مداخله
empty
Calculated with suggested formula
Calculated with suggested formula
empty
محاسبه شده با فرمولای پیشنهادی
محاسبه شده با فرمولای پیشنهادی
Secondary outcomes
#1
In serum sample will assessed by cholorimetric method. µmol/L
In plasma sample will assessed by cholorimetric method. µmol/L
In serumplasma sample will assessed by cholorimetric method. µmol/L
انجام آزمایش بر روی سرم به روش رنگ سنجی بر حسب میکرو مول بر لیتر
انجام آزمایش بر روی پلاسما به روش رنگ سنجی بر حسب میکرو مول بر لیتر
انجام آزمایش بر روی سرمپلاسما به روش رنگ سنجی بر حسب میکرو مول بر لیتر
#2
In serum sample will assessed by cholorimetric method. µmol/L
In plasma sample will assessed by cholorimetric method. µmol/L
In serumplasma sample will assessed by cholorimetric method. µmol/L
انجام آزمایش بر روی سرم به روش رنگ سنجی بر حسب میکرو مول بر لیتر
انجام آزمایش بر روی پلاسما به روش رنگ سنجی بر حسب میکرو مول بر لیتر
انجام آزمایش بر روی سرمپلاسما به روش رنگ سنجی بر حسب میکرو مول بر لیتر
#3
In serum sample will assessed by cholorimetric method. µmol/L
In plasma sample will assessed by cholorimetric method. µmol/L
In serumplasma sample will assessed by cholorimetric method. µmol/L
انجام آزمایش بر روی سرم به روش رنگ سنجی بر حسب میکرو مول بر لیتر
انجام آزمایش بر روی پلاسما به روش رنگ سنجی بر حسب میکرو مول بر لیتر
انجام آزمایش بر روی سرمپلاسما به روش رنگ سنجی بر حسب میکرو مول بر لیتر
#4
empty
High-sensitivity C-reactive protein
High-sensitivity C-reactive protein
empty
پروتئین واکنشگر C با حساسیت بالا
پروتئین واکنشگر C با حساسیت بالا
empty
At the beginning of the study and 12 weeks after intervention
At the beginning of the study and 12 weeks after intervention
empty
در ابتدای مطالعه و 12 هفته بعد از مداخله
در ابتدای مطالعه و 12 هفته بعد از مداخله
empty
Elisa kit
Elisa kit
empty
کیت الایزا
کیت الایزا
#5
empty
Nitric oxide
Nitric oxide
empty
نیتریک اکساید
نیتریک اکساید
empty
At the beginning of the study and 12 weeks after intervention
At the beginning of the study and 12 weeks after intervention
empty
در ابتدای مطالعه و 12 هفته بعد از مداخله
در ابتدای مطالعه و 12 هفته بعد از مداخله
empty
In plasma sample will assessed by cholorimetric method. µmol/L
In plasma sample will assessed by cholorimetric method. µmol/L
empty
انجام آزمایش بر روی پلاسما به روش رنگ سنجی بر حسب میکرو مول بر لیتر
انجام آزمایش بر روی پلاسما به روش رنگ سنجی بر حسب میکرو مول بر لیتر
#6
empty
Beck score
Beck score
empty
امتیاز بک
امتیاز بک
empty
At the beginning of the study and after 12 weeks of intervention
At the beginning of the study and after 12 weeks of intervention
empty
در ابتدای مطالعه و 12 هفته بعد از مداخله
در ابتدای مطالعه و 12 هفته بعد از مداخله
empty
Questionnaire
Questionnaire
empty
پرسشنامه
پرسشنامه
#7
empty
GHQ score
GHQ score
empty
امتیاز سلامت عمومی
امتیاز سلامت عمومی
empty
At the beginning of the study and after 12 weeks of intervention
At the beginning of the study and after 12 weeks of intervention
empty
در ابتدای مطالعه و 12 هفته بعد از مداخله
در ابتدای مطالعه و 12 هفته بعد از مداخله
empty
Questionnaire
Questionnaire
empty
پرسشنامه
پرسشنامه
#8
empty
DASS-28 score
DASS-28 score
empty
امتیاز DASS-28
امتیاز DASS-28
empty
At the beginning of the study and after 12 weeks of intervention
At the beginning of the study and after 12 weeks of intervention
empty
در ابتدای مطالعه و 12 هفته بعد از مداخله
در ابتدای مطالعه و 12 هفته بعد از مداخله
empty
Questionnaire
Questionnaire
empty
پرسشنامه
پرسشنامه
#9
empty
Modified Ferriman Gallwey
Modified Ferriman Gallwey
empty
فری من گال وی تعدیل شده
فری من گال وی تعدیل شده
empty
At the beginning of the study and after 12 weeks of intervention
At the beginning of the study and after 12 weeks of intervention
empty
در ابتدای مطالعه و 12 هفته بعد از مداخله
در ابتدای مطالعه و 12 هفته بعد از مداخله
empty
Questionnaire
Questionnaire
empty
پرسشنامه
پرسشنامه
#10
empty
Triglycerides
Triglycerides
empty
تری گلیسرید
تری گلیسرید
empty
At the beginning of the study and after 12 weeks of intervention
At the beginning of the study and after 12 weeks of intervention
empty
در ابتدای مطالعه و 12 هفته بعد از مداخله
در ابتدای مطالعه و 12 هفته بعد از مداخله
empty
Enzymatic kit
Enzymatic kit
empty
کیت آنزیمی
کیت آنزیمی
#11
empty
VLDL-cholesterol
VLDL-cholesterol
empty
کلسترول VLDL
کلسترول VLDL
empty
At the beginning of the study and after 12 weeks of intervention
At the beginning of the study and after 12 weeks of intervention
empty
در ابتدای مطالعه و 12 هفته بعد از مداخله
در ابتدای مطالعه و 12 هفته بعد از مداخله
empty
Enzymatic kit
Enzymatic kit
empty
کیت آنزیمی
کیت آنزیمی
#12
empty
Total cholesterol
Total cholesterol
empty
توتال کلسترول
توتال کلسترول
empty
At the beginning of the study and after 12 weeks of intervention
At the beginning of the study and after 12 weeks of intervention
empty
در ابتدای مطالعه و 12 هفته بعد از مداخله
در ابتدای مطالعه و 12 هفته بعد از مداخله
empty
Enzymatic kit
Enzymatic kit
empty
کیت آنزیمی
کیت آنزیمی
#13
empty
LDL-cholesterol
LDL-cholesterol
empty
کلسترول LDL
کلسترول LDL
empty
At the beginning of the study and after 12 weeks of intervention
At the beginning of the study and after 12 weeks of intervention
empty
در ابتدای مطالعه و 12 هفته بعد از مداخله
در ابتدای مطالعه و 12 هفته بعد از مداخله
empty
Enzymatic kit
Enzymatic kit
empty
کیت آنزیمی
کیت آنزیمی
#14
empty
HDL-cholesterol
HDL-cholesterol
empty
کلسترول HDL
کلسترول HDL
empty
At the beginning of the study and after 12 weeks of intervention
At the beginning of the study and after 12 weeks of intervention
empty
در ابتدای مطالعه و 12 هفته بعد از مداخله
در ابتدای مطالعه و 12 هفته بعد از مداخله
empty
Enzymatic kit
Enzymatic kit
empty
کیت آنزیمی
کیت آنزیمی
#15
empty
Fasting plasma glucose
Fasting plasma glucose
empty
قند خون پلاسمایی ناشتا
قند خون پلاسمایی ناشتا
empty
At the beginning of the study and after 12 weeks of intervention
At the beginning of the study and after 12 weeks of intervention
empty
در ابتدای مطالعه و 12 هفته بعد از مداخله
در ابتدای مطالعه و 12 هفته بعد از مداخله
empty
Enzymatic kit
Enzymatic kit
empty
کیت آنزیمی
کیت آنزیمی
Recruitment centers
#1
Name of recruitment center - English: Women's Clinic of Naghavi Hospital
Name of recruitment center - Persian: کلینیک زنان بیمارستان نقوی
Full name of responsible person - English: Dr. Fatemeh Forouzan Fard
Full name of responsible person - Persian: دکتر فاطمه فروزان فرد
Street address - English: Ayatollah Kashai Avenue, Naghavi Hospital
Street address - Persian: خیابان آیت اله کاشانی، بیمارستان نقوی
City - English: Kashan
City - Persian: کاشان
Province:
Country: Iran (Islamic Republic of)
Postal code:
Phone:
Fax:
Email:
Web page address:
Name of recruitment center - English: Women's Clinic of Naghavi Hospital
Name of recruitment center - Persian: کلینیک زنان بیمارستان نقوی
Full name of responsible person - English: Dr. Fatemeh Forouzan Fard
Full name of responsible person - Persian: دکتر فاطمه فروزان فرد
Street address - English: Naghavi Hospital, Ayatollah Kashai Ave
Street address - Persian: بیمارستان نقوی، خیابان آیت اله کاشانی
City - English: Kashan
City - Persian: کاشان
Province: Isfehan
Country: Iran (Islamic Republic of)
Postal code: 8715988141
Phone: +98 31 5554 0021
Fax:
Email: fbahmani@kaums.ac.ir
Web page address:
Name of recruitment center - English: Women's Clinic of Naghavi Hospital Name of recruitment center - Persian: کلینیک زنان بیمارستان نقوی Full name of responsible person - English: Dr. Fatemeh Forouzan Fard Full name of responsible person - Persian: دکتر فاطمه فروزان فرد Street address - English: Naghavi Hospital, Ayatollah Kashai Avenue, Naghavi HospitalAve Street address - Persian: بیمارستان نقوی، خیابان آیت اله کاشانی، بیمارستان نقوی City - English: Kashan City - Persian: کاشان Province: Isfehan Country: Iran (Islamic Republic of) Postal code: 8715988141 Phone: +98 31 5554 0021 Fax: Email: fbahmani@kaums.ac.ir Web page address:
Sponsors / Funding sources
#1
contact.organization_id:
Name of organization / entity - English: Vice chancellor for research, Kashan University of Medical Sciences
Name of organization / entity - Persian: معاونت پژوهشی، دانشگاه علوم پزشکی کاشان
Full name of responsible person - English: Dr. Gholam Ali Hamidi
Full name of responsible person - Persian: دکتر غلامعلی حمیدی
Street address - English: Vice chancellor for research, Kashan University of Medical Sciences ,Ravand road
Street address - Persian: جاده راوند، دانشگاه علوم پزشکی کاشان، معاونت پژوهشی دانشگاه
City - English: Kashan
City - Persian: کاشان
Province:
Country: Iran (Islamic Republic of)
Postal code:
Phone:
Fax:
Email:
Web page address:
Name of organization / entity - English:
Name of organization / entity - Persian:
Full name of responsible person - English: Dr. Gholam Ali Hamidi
Full name of responsible person - Persian: دکتر غلامعلی حمیدی
Street address - English: Vice chancellor for research, Kashan University of Medical Sciences ,Ravand road
Street address - Persian: معاونت پژوهشی دانشگاه، دانشگاه علوم پزشکی کاشان، جاده راوند
City - English: Kashan
City - Persian: کاشان
Province: Isfehan
Country: Iran (Islamic Republic of)
Postal code: 8715988141
Phone: +98 31 5554 2999
Fax:
Email: hamidi_gh@kaums.ac.ir
Web page address:
contact.organization_id: Name of organization / entity - English: Vice chancellor for research, Kashan University of Medical Sciences Name of organization / entity - Persian: معاونت پژوهشی، دانشگاه علوم پزشکی کاشان Full name of responsible person - English: Dr. Gholam Ali Hamidi Full name of responsible person - Persian: دکتر غلامعلی حمیدی Street address - English: Vice chancellor for research, Kashan University of Medical Sciences ,Ravand road Street address - Persian: جاده راوندمعاونت پژوهشی دانشگاه، دانشگاه علوم پزشکی کاشان، معاونت پژوهشی دانشگاهجاده راوند City - English: Kashan City - Persian: کاشان Province: Isfehan Country: Iran (Islamic Republic of) Postal code: 8715988141 Phone: +98 31 5554 2999 Fax: Email: hamidi_gh@kaums.ac.ir Web page address:
Protocol summary
Study aim
The effects of fish oil supplementation on hormonal profiles and oxidative stress parameters in patients with polycystic ovary syndrome
Design
In this research, 60 patients with polycystic ovary syndrome who are eligible will be selected. Participants are randomly divided into two groups of intervention and control by computer software.
The design of the study is parallel blind randomized clinical trial.
Settings and conduct
60 patients with polycystic ovary syndrome who are eligible and are referred to women sections of Naghavii hospital affiliated to Kashan University of Medical Sciences, Kashan, Iran will be selected.
The design of the study is a double blind randomized clinical tria. Blinding is carried out for patients and researchers and randomization is done by random table numbers.
Patients will be assigned to receive either fish oil (intervention group: n=30) or placebo (control group: n=30). Fasting blood samples will be taken at baseline and after 12 week intervention
Participants/Inclusion and exclusion criteria
Inclusion Criteria: Women with polycystic ovary syndrome aged 18 to 35 years, on the basis of Rotterdam criteria and without smoking abuse will be included in this study.
Exclusion Criteria: Patients who do not want to cooperate؛ patients with polycystic ovary syndrome with revealed diabetes, hypo or hyperthyroidism, hyperprolactinemia are excluded from this study.
Intervention groups
Patients will be assigned to receive either fish oil (intervention group: n=30) or placebo (control group: n=30).
Main outcome variables
serum levels of total testosterone, Free testosterone, DHEA sulfate, SHBG, oxidative stress factors such as malondialdehyde (MDA), glutathione (GSH), total antioxidant capacity will be measured.
General information
Reason for update
The updating process was done after publishing the paper to correct the registration information.
Acronym
IRCT registration information
IRCT registration number:IRCT20150606022562N4
Registration date:2018-02-17, 1396/11/28
Registration timing:retrospective
Last update:2023-04-22, 1402/02/02
Update count:1
Registration date
2018-02-17, 1396/11/28
Registrant information
Name
Fereshteh Bahmani
Name of organization / entity
Kashan University of Medical Sciences
Country
Iran (Islamic Republic of)
Phone
+98 31 5554 0021
Email address
fbahmani@kaums.ac.ir
Recruitment status
Recruitment complete
Funding source
Vice chancellor for research, Kashan University of Medical Sciences
Expected recruitment start date
2017-12-01, 1396/09/10
Expected recruitment end date
2017-12-31, 1396/10/10
Actual recruitment start date
empty
Actual recruitment end date
empty
Trial completion date
empty
Scientific title
The effects of fish oil supplementation on hormonal profiles and oxidative stress parameters in patients with polycystic ovary syndrome
Public title
The effect of fish oil in patients with polycystic ovary syndrome
Purpose
Treatment
Inclusion/Exclusion criteria
Inclusion criteria:
Women aged 18-35
Polycystic ovary syndrome on the basis of Rotterdam criteria
No smoking
Exclusion criteria:
Revealed diabetes
Hypothyroidism or hyperthyroidism
Hyperprolactinemia
Cushing's syndrome and adrenal and ovarian tumors
Unwillingness to continue cooperation
No regular use of the prescribed supplement
Age
From 18 years old to 35 years old
Gender
Female
Phase
2
Groups that have been masked
Participant
Care provider
Investigator
Outcome assessor
Data analyser
Sample size
Target sample size:
60
Randomization (investigator's opinion)
Randomized
Randomization description
The method of randomization is that women with PCOS are based on two criteria:
BMI (25BMI <and 25BMI≥) and age (30 and 30 ≤) in the stratification
they take. The method of randomization with a simple method and the use of random numbers generated by computer software will be performed.
Blinding (investigator's opinion)
Double blinded
Blinding description
In this study, participants, researchers, data collectors, evaluators and data analyzers are not aware of which group of placebo and supplemented fish oil groups.
Placebo
Used
Assignment
Parallel
Other design features
Secondary Ids
empty
Ethics committees
1
Ethics committee
Name of ethics committee
Ethics Committee of Kashan university of medical sciences and health services
Street address
Kashan University of Medical Sciences, Ravand road
City
Kashan
Province
Isfehan
Postal code
8715988141
Approval date
2017-10-19, 1396/07/27
Ethics committee reference number
IR.KAUMS.MEDNT.REC.1396.25
Health conditions studied
1
Description of health condition studied
polycystic ovary syndrome
ICD-10 code
E28.2
ICD-10 code description
Polycystic ovarian syndrome
Primary outcomes
1
Description
Total Testosterone
Timepoint
At the beginning of the study and 12 weeks after intervention
Method of measurement
ELISA kit
2
Description
SHBG
Timepoint
At the beginning of the study and 12 weeks after intervention
Method of measurement
ELISA kit
3
Description
Serum insulin
Timepoint
At the beginning of the study and 12 weeks after intervention
Method of measurement
Elisa kit
4
Description
Insulin resistance
Timepoint
At the beginning of the study and 12 weeks after intervention
Method of measurement
Calculated with suggested formula
5
Description
Insulin sensitivity
Timepoint
At the beginning of the study and 12 weeks after intervention
Method of measurement
Calculated with suggested formula
Secondary outcomes
1
Description
Total Gluthatione
Timepoint
At the beginning of the study and 12 weeks after intervention
Method of measurement
In plasma sample will assessed by cholorimetric method. µmol/L
2
Description
plasma total antioxidant
Timepoint
At the beginning of the study and 12 weeks after intervention
Method of measurement
In plasma sample will assessed by cholorimetric method. µmol/L
3
Description
Malondialdehyde (MAD)
Timepoint
At the beginning of the study and 12 weeks after intervention
Method of measurement
In plasma sample will assessed by cholorimetric method. µmol/L
4
Description
High-sensitivity C-reactive protein
Timepoint
At the beginning of the study and 12 weeks after intervention
Method of measurement
Elisa kit
5
Description
Nitric oxide
Timepoint
At the beginning of the study and 12 weeks after intervention
Method of measurement
In plasma sample will assessed by cholorimetric method. µmol/L
6
Description
Beck score
Timepoint
At the beginning of the study and after 12 weeks of intervention
Method of measurement
Questionnaire
7
Description
GHQ score
Timepoint
At the beginning of the study and after 12 weeks of intervention
Method of measurement
Questionnaire
8
Description
DASS-28 score
Timepoint
At the beginning of the study and after 12 weeks of intervention
Method of measurement
Questionnaire
9
Description
Modified Ferriman Gallwey
Timepoint
At the beginning of the study and after 12 weeks of intervention
Method of measurement
Questionnaire
10
Description
Triglycerides
Timepoint
At the beginning of the study and after 12 weeks of intervention
Method of measurement
Enzymatic kit
11
Description
VLDL-cholesterol
Timepoint
At the beginning of the study and after 12 weeks of intervention
Method of measurement
Enzymatic kit
12
Description
Total cholesterol
Timepoint
At the beginning of the study and after 12 weeks of intervention
Method of measurement
Enzymatic kit
13
Description
LDL-cholesterol
Timepoint
At the beginning of the study and after 12 weeks of intervention
Method of measurement
Enzymatic kit
14
Description
HDL-cholesterol
Timepoint
At the beginning of the study and after 12 weeks of intervention
Method of measurement
Enzymatic kit
15
Description
Fasting plasma glucose
Timepoint
At the beginning of the study and after 12 weeks of intervention
Method of measurement
Enzymatic kit
Intervention groups
1
Description
Intervention: received two capsules of 1gr fish oil daily for 12 weeks
Category
Treatment - Other
2
Description
control: received two capsules of placebo daily for 12 weeks
Category
Placebo
Recruitment centers
1
Recruitment center
Name of recruitment center
Women's Clinic of Naghavi Hospital
Full name of responsible person
Dr. Fatemeh Forouzan Fard
Street address
Naghavi Hospital, Ayatollah Kashai Ave
City
Kashan
Province
Isfehan
Postal code
8715988141
Phone
+98 31 5554 0021
Email
fbahmani@kaums.ac.ir
Sponsors / Funding sources
1
Sponsor
Name of organization / entity
Kashan University of Medical Sciences
Full name of responsible person
Dr. Gholam Ali Hamidi
Street address
Vice chancellor for research, Kashan University of Medical Sciences ,Ravand road
City
Kashan
Province
Isfehan
Postal code
8715988141
Phone
+98 31 5554 2999
Email
hamidi_gh@kaums.ac.ir
Grant name
Grant code / Reference number
Is the source of funding the same sponsor organization/entity?
Yes
Title of funding source
Kashan University of Medical Sciences
Proportion provided by this source
100
Public or private sector
Public
Domestic or foreign origin
Domestic
Category of foreign source of funding
empty
Country of origin
Type of organization providing the funding
Academic
Person responsible for general inquiries
Contact
Name of organization / entity
Kashan University of Medical Sciences
Full name of responsible person
Fereshteh Bahmani
Position
Associate Professor/ Academic staff member of the Department of Clinical Biochemistry
Latest degree
Ph.D.
Other areas of specialty/work
Clinical Biochemistry
Street address
Medical Faculty, Kashan University of Medical Sciences, Ravand road
City
Kashan
Province
Isfehan
Postal code
8715988141
Phone
+98 31 5554 0021
Fax
Email
bahmani@kaums.ac.ir
Web page address
Person responsible for scientific inquiries
Contact
Name of organization / entity
Kashan University of Medical Sciences
Full name of responsible person
Fereshteh Bahmani
Position
Associate Professor/ Academic staff member of the Department of Clinical Biochemistry
Latest degree
Ph.D.
Other areas of specialty/work
Clinical Biochemistry
Street address
Medical Faculty, Kashan University of Medical Sciences, Ravand road
City
Kashan
Province
Isfehan
Postal code
8715988141
Phone
+98 31 5554 0021
Fax
Email
fbahmani@kaums.ac.ir
Web page address
Person responsible for updating data
Contact
Name of organization / entity
Kashan University of Medical Sciences
Full name of responsible person
Fereshteh Bahmani
Position
Associate Professor/ Academic staff member of the Department of Clinical Biochemistry
Latest degree
Ph.D.
Other areas of specialty/work
Clinical Biochemistry
Street address
Medical Faculty, Kashan University of Medical Sciences, Ravand road
City
Kashan
Province
Isfehan
Postal code
8715988141
Phone
+98 31 5554 0021
Fax
Email
fbahmani@kaums.ac.ir
Web page address
Sharing plan
Deidentified Individual Participant Data Set (IPD)
Undecided - It is not yet known if there will be a plan to make this available
Study Protocol
Undecided - It is not yet known if there will be a plan to make this available
Statistical Analysis Plan
Undecided - It is not yet known if there will be a plan to make this available
Informed Consent Form
Undecided - It is not yet known if there will be a plan to make this available
Clinical Study Report
Undecided - It is not yet known if there will be a plan to make this available
Analytic Code
Undecided - It is not yet known if there will be a plan to make this available
Data Dictionary
Undecided - It is not yet known if there will be a plan to make this available